Having more bacteria-fighting immune cells in the nose and throat may explain why some people are more likely to be infected by respiratory viruses.
Oct 9, 2020
0
159
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
Jul 9, 2020
0
1392
Researchers at UConn's Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published ...
Jun 17, 2020
0
63
As SARS-CoV-2 has the potential to mutate, it is important to check the efficacy of current diagnostic tests, say York University researchers, who found seven out of 27 methods had potential sequence mismatch issues that ...
Jun 10, 2020
0
154
New research from University of Alberta microbiologists has shed new light on how the respiratory syncytial virus (RSV)—one of the most common viral infections—breaks into our cells to cause infection.
Jun 3, 2020
0
146
Vaccines are one of the most effective interventions to prevent the spreading of infectious diseases. They trigger the immune system to produce antibodies that protect the body against infection. However, we still lack efficacious ...
May 14, 2020
2
344
A team of researchers from Nationwide Children's Hospital in the U.S. and Universidad de Málaga in Spain has found some clues that might explain why some young children develop stronger respiratory syncytial virus (RSV) ...
About one in five people with COVID-19 are also infected with other respiratory viruses, according to a preliminary analysis led by Ian Brown, MD, a clinical associate professor of emergency medicine at the Stanford School ...
Mar 30, 2020
3
1800
A vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success.
Oct 9, 2019
0
63
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial. A team of researchers, including ...
Aug 1, 2019
0
337
